We are live on ! Find out more
EC

EntryPoint Capital Portfolio holdings

AUM $341M
1-Year Est. Return 20.57%
This Fund
S&P 500
This Quarter Est. Return
+8.02%
1 Year Est. Return
+20.57%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$176M
AUM Growth
+$107M
Cap. Flow
+$103M
Cap. Flow %
58.75%
Top 10 Hldgs %
4.24%
Holding
1,234
New
413
Increased
180
Reduced
1
Closed
640

Top Buys

Rank Stock Value
1
GH icon
Guardant Health
GH
+$895K
2
PLAB icon
Photronics
PLAB
+$774K
3
EW icon
Edwards Lifesciences
EW
+$755K
4
MMS icon
Maximus
MMS
+$754K
5
TTEK icon
Tetra Tech
TTEK
+$745K

Top Sells

Rank Stock Value
1
DK icon
Delek US
DK
+$197K
2
CSGP icon
CoStar Group
CSGP
+$197K
3
VIST icon
Vista Energy
VIST
+$197K
4
SKX
Skechers
SKX
+$196K
5
ALRS icon
Alerus Financial
ALRS
+$195K

Sector Composition

Rank Sector Weight
1 Healthcare 19.45%
2 Technology 17.59%
3 Industrials 17.43%
4 Consumer Discretionary 12.31%
5 Financials 10.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BHE icon
476
Benchmark Electronics
BHE
$2.91B
$201K 0.11%
+4,541
New +$190K
OBK icon
477
Origin Bancorp
OBK
$1.66B
$201K 0.11%
+6,258
New +$204K
CECO icon
478
Ceco Environmental
CECO
$4.42B
$201K 0.11%
7,136
+2,058
+41% +$57.9K
CRWD icon
479
CrowdStrike
CRWD
$187B
$201K 0.11%
+2,864
New +$203K
BASE
480
DELISTED
Couchbase
BASE
$200K 0.11%
+12,376
New +$214K
ATRO icon
481
Astronics
ATRO
$3.45B
$198K 0.11%
+12,216
New +$207K
TALO icon
482
Talos Energy
TALO
$2.49B
$197K 0.11%
+19,039
New +$217K
VRE
483
DELISTED
Veris Residential
VRE
$196K 0.11%
10,994
+7,427
+208% +$122K
LGTY
484
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$195K 0.11%
+17,468
New +$181K
UDMY
485
DELISTED
Udemy
UDMY
$193K 0.11%
+25,947
New +$209K
LFMD icon
486
LifeMD
LFMD
$179M
$192K 0.11%
+36,567
New +$211K
SXC icon
487
SunCoke Energy
SXC
$757M
$190K 0.11%
+21,904
New +$203K
RERE
488
ATRenew
RERE
$859M
$190K 0.11%
+68,365
New +$166K
SLQT icon
489
SelectQuote
SLQT
$114M
$190K 0.11%
+87,502
New +$287K
AVO icon
490
Mission Produce
AVO
$1.1B
$190K 0.11%
+14,802
New +$164K
RLAY icon
491
Relay Therapeutics
RLAY
$4.02B
$187K 0.11%
+26,368
New +$197K
NUVB icon
492
Nuvation Bio
NUVB
$2.24B
$183K 0.1%
+79,922
New +$244K
VERV
493
DELISTED
Verve Therapeutics
VERV
$180K 0.1%
+37,174
New +$216K
BRKL
494
DELISTED
Brookline Bancorp
BRKL
$179K 0.1%
+17,694
New +$174K
PLRX icon
495
Pliant Therapeutics
PLRX
$67.5M
$178K 0.1%
+15,911
New +$199K
AUPH icon
496
Aurinia Pharmaceuticals
AUPH
$1.97B
$178K 0.1%
+24,230
New +$150K
GLUE icon
497
Monte Rosa Therapeutics
GLUE
$1.92B
$176K 0.1%
+33,219
New +$168K
EBS icon
498
Emergent Biosolutions
EBS
$375M
$175K 0.1%
+20,980
New +$191K
UMC icon
499
United Microelectronic
UMC
$48.9B
$175K 0.1%
+20,740
New +$174K
SVRA icon
500
Savara
SVRA
$1.13B
$174K 0.1%
+40,963
New +$181K
18 19
20
21 22

Similar funds

SFA
Seneca Financial Advisors Rochester, New York $341M AUM 14.73% 1-Year Est. Return
FCM
Findell Capital Management New York $341M AUM 135.6% 1-Year Est. Return
CPI
Crestview Partners II New York $341M AUM 17.29% 1-Year Est. Return
SW
SMART Wealth Omaha, Nebraska $341M AUM 24.37% 1-Year Est. Return
MTIC
Missouri Trust & Investment Company Springfield, Missouri $341M AUM 17.31% 1-Year Est. Return
KFSC
Keystone Financial Services (Colorado) Loveland, Colorado $341M AUM 18.11% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
SC
Slotnik Capital Dallas, Texas $342M AUM 105.92% 1-Year Est. Return

EntryPoint Capital's Q3 2024 Portfolio in Review

As of Q3 2024, EntryPoint Capital held 1,234 positions worth $176M, up 157% from $68.4M the previous quarter. Its ten largest holdings account for 4.2% of the portfolio.

EntryPoint Capital deployed $103M of net new capital in Q3 2024, opening 413 new positions and adding to 180 existing holdings. Its largest new stake was Guardant Health: 31,633 shares worth $726K.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 14% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was iRadimed, an estimated $8.4K trimmed.

  • EntryPoint Capital's largest Q3 2024 buy was Guardant Health: 31,633 shares worth $726K.
  • EntryPoint Capital added most to Edwards Lifesciences in Q3 2024, an estimated $755K increase.
  • EntryPoint Capital's biggest Q3 2024 reduction was iRadimed, cutting an estimated $8.4K.
  • EntryPoint Capital fully exited Delek US in Q3 2024, selling an estimated $197K.
  • EntryPoint Capital's ten largest holdings make up 4.2% of its $176M portfolio in Q3 2024.
  • EntryPoint Capital opened 413 new positions and closed 640 in Q3 2024.
  • EntryPoint Capital's portfolio value rose 157% quarter-over-quarter to $176M.

Based on EntryPoint Capital's 13F filing for Q3 2024, filed 13 Nov 2024.